U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 3...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news
Dozens in China Infected With New ‘Langya’ Virus Carried by Shrews
Nearly three dozen people in China have been sickened by a newly identified virus from the same family as the deadly Nipah and Hendra viruses, though there’s no evidence the pathogen can be transmitted from person-to-person.
The virus, named Langya henipavirus or LayV, was found thanks to an early detection system for feverish people with a recent history of exposure to animals in eastern China. The patients—mainly farmers—also reported fatigue, cough, loss of appetite and aches, with several developing blood-cell abnormalities and signs of liver and kidney damage. All survived.
Among the 35 patients, 26 ...
Source: TIME: Health - August 10, 2022 Category: Consumer Health News Authors: Michelle Fay Cortez/Bloomberg Tags: Uncategorized Disease healthscienceclimate wire Source Type: news
Is Langya Henipavirus, LayV, A New Virus Threat? 35 People In China Infected
The LayV is part of the same family as the deadly Hendra and the Nipah viruses. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 10, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
NIH launches clinical trial of mRNA Nipah virus vaccine
Nipah virus infection is spread between animals and people. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 11, 2022 Category: American Health Source Type: news
NIH launches clinical trial of mRNA Nipah virus vaccine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an investigational vaccine to prevent infection with Nipah virus. The experimental vaccine is manufactured by Moderna, Inc., (Cambridge, Massachusetts) and was developed in collaboration with NIAID's Vaccine Research Center. It is based on a messenger RNA (mRNA) platform - a technology used in several approved COVID-19 vaccines. (Source: World Pharma News)
Source: World Pharma News - July 11, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Two Emerging Viral Adversaries —Nipah And Hendra Virus—May Soon Meet Their Match
Nipah and Hendra Virus are two dangerous emerging pathogens that may cause serious damage if left unchecked. Here we analyze antibody candidates that may impede these threats. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 11, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Professor Sarah Gilbert on the legacy of lockdown: We must ensure we are better prepared for future outbreaks
The pandemic has taught us that viruses are not easy to identify – and can spread like wildfireAs we move into the late stages of the pandemic, it is important to reflect on the scientific discoveries of the past two years, so that we are better prepared for future virus outbreaks. I believe there are two areas in particular where we can learn from the experience.The first is understanding that outbreaks are not always easy to identify quickly. Viruses such as Nipah and Ebola cause severe, and therefore obvious, illness in everyone who is infected. The fatality rate is high but transmissibility is low, with an R number â...
Source: Guardian Unlimited Science - March 18, 2022 Category: Science Authors: Prof Sarah Gilbert Tags: Coronavirus Infectious diseases Medical research Science Microbiology Vaccines and immunisation Health Society AstraZeneca Source Type: news
Scientists develop Nipah virus vaccine that 'gives lifesaving protection in three DAYS'
In an animal study by Texas researchers, 100 per cent of monkeys given the jab seven days before a lethal dose of the disease survived. Two-thirds given the shot three days in advance lived. (Source: the Mail online | Health)
Source: the Mail online | Health - March 14, 2022 Category: Consumer Health News Source Type: news
Moderna Is Sharing Its Vaccine Technology With Low-Income Countries. But That Doesn ’t Mean Locally Produced Shots Are Coming Soon
Moderna, the Massachusetts-based company behind one of the two mRNA COVID-19 vaccines, made the decision in 2020 not to enforce the patent on its shot. The move was meant to encourage low- and middle-income countries that couldn’t afford to purchase billions of doses of the vaccine (as the U.S., Canada, and many European countries had done) to develop their own versions of the shot using less expensive resources.
On Mar. 8, Moderna went a step further, saying that it will now extend that promise indefinitely in the 92 low- and middle-income countries that are receiving doses from COVAX, the global vaccine distributio...
Source: TIME: Health - March 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Architecture and antigenicity of the Nipah virus attachment glycoprotein
Science,<a href="https://www.science.org/toc/science/375/6587">Volume 375, Issue 6587</a>, Page 1373-1378, March 2022. (Source: ScienceNOW)
Source: ScienceNOW - March 3, 2022 Category: Science Authors: Zhaoqian Wang, Moushimi Amaya, Amin Addetia, Ha V. Dang, Gabriella Reggiano, Lianying Yan, Andrew C. Hickey, Frank DiMaio, Christopher C. Broder, David Veesler Source Type: news
What Is the Treatment for Nipah Virus
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 27, 2021 Category: General Medicine Source Type: news
How the hunt for this deadly virus shaped the search for coronavirus’s origins
Scientists quickly identified the deadly Nipah virus, tracing it to fruit bats. The detective story is taking on new relevance as scientists hunt for the origins of coronavirus and as zoonotic spillover is happening with increasing frequency, heightening the possibility of more pandemics in the future. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 14, 2021 Category: Consumer Health News Authors: Karin Brulliard Source Type: news
Why There Are Fears That Nipah Virus Could One Day Cause A Deadly Pandemic : Goats and Soda
(Source: Reuters: Health)
Source: Reuters: Health - September 12, 2021 Category: Consumer Health News Source Type: news
Molbio Diagnostics gets DCGI nod for Nipah virus testing
Nipah virus testing can now be performed rapidly on Truenat, a real-time PCR platform, on demand, the Goa-based firm said. This will result in early and fast diagnosis for effective management of the disease and containment of the spread of Nipah virus, it added. (Source: The Economic Times)
Source: The Economic Times - September 8, 2021 Category: Consumer Health News Source Type: news
Nipah Virus Kills 12-Year-Old Boy In India, Raising Outbreak Concerns
The Nipah Virus is already on the list of infectious diseases with "pandemic potential." (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 7, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
